Impact of pharmacist-physician collaborative care on hemoglobin A1c and blood pressure quality measure achievement in primary care.

IF 2.3 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Tyler D Wagner, Dave L Dixon, Yongyun Shin, Mikhail Dozmorov, Kerri T Musselman, Tonya M Buffington, Haroon Hyder, Bryan Kirschner, Resa M Jones, Teresa M Salgado
{"title":"Impact of pharmacist-physician collaborative care on hemoglobin A1c and blood pressure quality measure achievement in primary care.","authors":"Tyler D Wagner, Dave L Dixon, Yongyun Shin, Mikhail Dozmorov, Kerri T Musselman, Tonya M Buffington, Haroon Hyder, Bryan Kirschner, Resa M Jones, Teresa M Salgado","doi":"10.18553/jmcp.2025.31.6.565","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Multidisciplinary primary care models incorporating pharmacists have emerged to improve glycemic control in patients with uncontrolled type 2 diabetes mellitus (T2DM). Healthcare Effectiveness Data and Information Set (HEDIS) measures establish quality benchmarks for comprehensive diabetes care and guide reimbursement. Large-scale research on the effect of pharmacist interventions to improve these quality measures in primary care remains limited.</p><p><strong>Objective: </strong>To evaluate the effectiveness of a pharmacist-physician collaborative care (PPCC) model on comprehensive diabetes care quality measure achievement compared with standard care (SC).</p><p><strong>Methods: </strong>This retrospective cohort study included adults aged 18 to 75 years with uncontrolled T2DM receiving care in primary care clinics at a community-based health system in Virginia from July 1, 2018, to December 31, 2019. Patients were in one of 2 groups: (1) the intervention group (PPCC), where embedded pharmacists provided diabetes management under a collaborative practice agreement, and (2) the comparator group receiving SC in clinics without pharmacists. The SC group was created via 1:2 propensity score matching. Generalized linear mixed models assessed the association between group and quality measure achievement. Primary outcomes included glycated hemoglobin (hemoglobin A1c) (≤9%, ≤8%, ≤7%) and blood pressure control (<140/90 mm Hg), per the last recorded value in 2019.</p><p><strong>Results: </strong>The sample (N = 1,293) had a mean age of 57 years, was 56% female, and 45% each White and Black. The PPCC group (n = 431) was more likely to achieve A1c control compared with the SC group (n = 862) (A1c <9%: odds ratio [OR] = 3.68, 95% CI = 2.31-5.84; A1c <8%: OR = 3.53, 95% CI = 2.12-5.89; A1c <7%: OR = 4.61, 95% CI = 2.48-8.56; all <i>P</i> < 0.01). Similarly, the PPCC group was more likely to achieve blood pressure control less than 140/90 mm Hg (OR = 1.49, 95% CI = 1.01-2.22; <i>P</i> = 0.04).</p><p><strong>Conclusions: </strong>Patients in the PPCC group were more likely to meet comprehensive diabetes care quality measures compared with SC. These results underscore the value of pharmacists in diabetes management in primary care and their contribution to value-based care.</p>","PeriodicalId":16170,"journal":{"name":"Journal of managed care & specialty pharmacy","volume":"31 6","pages":"565-577"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12123200/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of managed care & specialty pharmacy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18553/jmcp.2025.31.6.565","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Multidisciplinary primary care models incorporating pharmacists have emerged to improve glycemic control in patients with uncontrolled type 2 diabetes mellitus (T2DM). Healthcare Effectiveness Data and Information Set (HEDIS) measures establish quality benchmarks for comprehensive diabetes care and guide reimbursement. Large-scale research on the effect of pharmacist interventions to improve these quality measures in primary care remains limited.

Objective: To evaluate the effectiveness of a pharmacist-physician collaborative care (PPCC) model on comprehensive diabetes care quality measure achievement compared with standard care (SC).

Methods: This retrospective cohort study included adults aged 18 to 75 years with uncontrolled T2DM receiving care in primary care clinics at a community-based health system in Virginia from July 1, 2018, to December 31, 2019. Patients were in one of 2 groups: (1) the intervention group (PPCC), where embedded pharmacists provided diabetes management under a collaborative practice agreement, and (2) the comparator group receiving SC in clinics without pharmacists. The SC group was created via 1:2 propensity score matching. Generalized linear mixed models assessed the association between group and quality measure achievement. Primary outcomes included glycated hemoglobin (hemoglobin A1c) (≤9%, ≤8%, ≤7%) and blood pressure control (<140/90 mm Hg), per the last recorded value in 2019.

Results: The sample (N = 1,293) had a mean age of 57 years, was 56% female, and 45% each White and Black. The PPCC group (n = 431) was more likely to achieve A1c control compared with the SC group (n = 862) (A1c <9%: odds ratio [OR] = 3.68, 95% CI = 2.31-5.84; A1c <8%: OR = 3.53, 95% CI = 2.12-5.89; A1c <7%: OR = 4.61, 95% CI = 2.48-8.56; all P < 0.01). Similarly, the PPCC group was more likely to achieve blood pressure control less than 140/90 mm Hg (OR = 1.49, 95% CI = 1.01-2.22; P = 0.04).

Conclusions: Patients in the PPCC group were more likely to meet comprehensive diabetes care quality measures compared with SC. These results underscore the value of pharmacists in diabetes management in primary care and their contribution to value-based care.

药师-医师协同护理对初级保健中糖化血红蛋白和血压质量测量成果的影响。
背景:结合药师的多学科初级保健模式已经出现,以改善未控制的2型糖尿病(T2DM)患者的血糖控制。医疗保健有效性数据和信息集(HEDIS)措施建立了全面糖尿病护理的质量基准,并指导报销。大规模研究药师干预的影响,以提高这些质量措施在初级保健仍然有限。目的:评价药师-医师合作护理(PPCC)模式与标准护理(SC)模式对糖尿病综合护理质量测量成果的影响。方法:本回顾性队列研究纳入了2018年7月1日至2019年12月31日期间在弗吉尼亚州社区卫生系统初级保健诊所接受治疗的18至75岁未控制的2型糖尿病成年人。患者分为两组:(1)干预组(PPCC),其中嵌入的药剂师根据合作实践协议提供糖尿病管理;(2)比较组在没有药剂师的诊所接受SC。SC组采用1:2倾向评分匹配。广义线性混合模型评估了群体和质量测量成果之间的关系。主要结局包括糖化血红蛋白(血红蛋白A1c)(≤9%,≤8%,≤7%)和血压控制(结果:样本(N = 1,293)平均年龄57岁,女性56%,白人和黑人各45%。与SC组(n = 862)相比,PPCC组(n = 431)更有可能实现A1c控制(A1c P = 0.04)。结论:与SC相比,PPCC组患者更有可能满足糖尿病综合护理质量指标。这些结果强调了药师在初级保健糖尿病管理中的价值及其对价值护理的贡献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of managed care & specialty pharmacy
Journal of managed care & specialty pharmacy Health Professions-Pharmacy
CiteScore
3.50
自引率
4.80%
发文量
131
期刊介绍: JMCP welcomes research studies conducted outside of the United States that are relevant to our readership. Our audience is primarily concerned with designing policies of formulary coverage, health benefit design, and pharmaceutical programs that are based on evidence from large populations of people. Studies of pharmacist interventions conducted outside the United States that have already been extensively studied within the United States and studies of small sample sizes in non-managed care environments outside of the United States (e.g., hospitals or community pharmacies) are generally of low interest to our readership. However, studies of health outcomes and costs assessed in large populations that provide evidence for formulary coverage, health benefit design, and pharmaceutical programs are of high interest to JMCP’s readership.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信